What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden
- 29 December 2004
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 14 (5) , 341-348
- https://doi.org/10.1002/pds.1055
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefitPharmacoepidemiology and Drug Safety, 2003
- Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in AustraliaPharmacoepidemiology and Drug Safety, 2001
- A comparative analysis of generics markets in five European countriesHealth Policy, 2000
- Consumer Perceptions of Risk and Required Cost Savings for Generic Prescription DrugsJournal of the American Pharmaceutical Association, 2000
- Trends of generic substitution in community pharmacies.International Journal of Clinical Pharmacy, 1999
- What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?Health Policy, 1998
- Providing Incentives to Control Health Care Costs and Remain Competitive in the MarketplaceHealth Marketing Quarterly, 1998
- Fundholders' prescribing costs: the first five yearsBMJ, 1996